← SynDRA
AZILSARTAN MEDOXOMIL
SynDRA canonical compound SYN0029185 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | AGTR2 |
|---|
| Mechanism of action | Angiotensin receptor antagonist |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Insulin sensitizer
- Angiotensin antagonist
- Angiotensin receptor antagonist
- AGTR1 ANTAGONIST
- Type-1 angiotensin II receptor antagonist
- AGTR1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Angiotensin 2 Receptor Blocker
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin Receptor Antagonists
- Angiotensin 2 Type 1 Receptor Antagonists
ATC classes
- C09C · ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
- ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
Cross-references
Synonyms
- AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE
- EDARBI
- EDARBYCLOR
- Edarbi
- TAK 491
- edarbi
- azilsartan kamedoxomil
- Azilsartan medoxomilo
- AR-14
- TAK-491
- azilsartan-medoxomil
- Azilsartan
- TAK 536
- Azilsartan (TAK-536)
- CHEMBL57242
- F9NUX55P23
- TAK536
- CHEBI:68850
- Azilsartan [USAN]
- Azilsartan [USAN:INN]
- UNII-F9NUX55P23
- HSDB 8208
- Azilsartan- Bio-X
- Azilsartan free acid
- Azilva (TN)
- AZILSARTAN [MI]
- AZILSARTAN [INN]
- AZILSARTAN [JAN]
- AZILSARTAN [VANDF]
- AZILSARTAN [MART.]
- AZILSARTAN [WHO-DD]
- Azilsartan (JAN/USAN/INN)
- SCHEMBL167538
- GTPL6901
- Azilsartan, >=98% (HPLC)
- AMY4360
- DTXSID70163712
Reported adverse events
- Angioedema
- Hypotension
- Dizziness
- Fatigue
- Pruritus
- Loss of consciousness
- Rash
Look up AZILSARTAN MEDOXOMIL in the interactive SynDRA portal →